Insulet's Welcome Program for Animas ® Users Now Includes Optional Dexcom G5 ® Mobile CGM Upgrade BILLERICA, Mass --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company) the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod
People with diabetes in certain European countries, Australia and China to have access to Insulet's innovative, tubeless insulin pump for the first time
Transaction Accretive in Second Half of 2011, Expected to Accelerate Path to Profitability Expands Sales and Support Infrastructure to Drive Continued US Commercial Expansion Brings Over 60,000 New Customers to Insulet, Including Over 13,000 on Multiple Daily Insulin Injection Therapy
BILLERICA, MA -- ( Marketwired ) -- 03/30/15 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod ® Insulin Management System, today announced that Michael Levitz will be appointed Insulet's Chief Financial Officer starting May 4, 2015 .